Pharmaceutical
Activist Investor Bluebell Takes Stake In GSK
Activist investor Bluebell Capital Partners has taken a stake worth about €10 million in British pharmaceuticals group GlaxoSmithKline in efforts to s...
GSK To Boost Spending Power Of Pharma Business Post Break-up
GlaxoSmithKline will lay out plans to boost the spending power of its research-focused pharmaceuticals business at an investor day on Wednesday, as analyst...
Copyright © 2024. All rights reserved. Developed by Square1 and powered by PublisherPlus.com